Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS.

J Atheroscler Thromb · 2017 · PMC5656766 · PMID 28302952

Europe PMC DOI

hedged sentences

0.0360

closest p · 0.7× alpha

0.0360

boldest claim

The sentences

clearly significantp = 0.036actually significant

The increased risk for recurrent stroke and all vascular events in the top tertile remained clearly significant after additional adjustment for age, sex, BMI, HDL-C, TG, FBS, smoking, and statin use ( p = 0.036 and p = 0.002, respectively, Table 3 ).

also in 480 other papers

of borderline significanceno p-value reported

The difference between the median Hs-CRP level in patients with recurrent stroke (median 682 μg/L, IQR, 374–1530) and without (median 644 μg/L, IQR, 353–1230) was only of borderline significance.

also in 2,436 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.